Ifg Advisory, LLC Eli Lilly & CO Transaction History

Ifg Advisory, LLC

$1.54 Billion
Q3 2024

A detailed history of Ifg Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ifg Advisory, LLC holds 2,798 shares of LLY stock, worth $2.23 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,798

Previous 2,980 6.11%

Holding current value

$2.23 Million

Previous $2.7 Million 8.15%

% of portfolio

0.16%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $140,529 - $174,723	-182 Reduced 6.11%	2,798 $2.48 Million
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $128,301 - $160,900	-177 Reduced 5.61%	2,980 $2.7 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $100,081 - $133,895	169 Added 5.66%	3,157 $2.46 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $59,871 - $70,580	-114 Reduced 3.68%	2,988 $1.74 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $1.35 Million - $1.86 Million	3,102 New	3,102 $1.67 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $12,114 - $14,227	-39 Reduced 1.48%	2,590 $889,000
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $185,534 - $216,184	-577 Reduced 18.0%	2,629 $961,000
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $209,611 - $238,874	707 Added 28.29%	3,206 $1.04 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $29,266 - $34,363	105 Added 4.39%	2,499 $810,000
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $469 - $583	2 Added 0.08%	2,394 $685,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $89,715 - $111,336	399 Added 20.02%	2,392 $660,000
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $443 - $545	-2 Reduced 0.1%	1,993 $460,000
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $14,624 - $18,916	-81 Reduced 3.9%	1,995 $458,000
Q1 2021 Apr 19, 2021	BUY	$164.32 - $212.72 $117,981 - $152,732	718 Added 52.87%	2,076 $387,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $177,164 - $234,431	1,358 New	1,358 $229,000
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $192,571 - $222,744	-1,317 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $24,692 - $29,716	-181 Reduced 12.08%	1,317 $216,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $178,336 - $220,730	1,498 New	1,498 $207,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Account